MANUELA MENDES: Open Payments
NPI 1912904988 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,340 in 101 payments from 29 companies in 2025. Trend: 2023 $2,452 · 2024 $2,327 · 2025 $2,340
Food & beverage: $2,340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $441 |
| AstraZeneca Pharmaceuticals LP | 9 | $282 |
| Ardelyx, Inc. | 8 | $172 |
| Phathom Pharmaceuticals, Inc. | 7 | $149 |
| GlaxoSmithKline, LLC. | 6 | $144 |
| Verona Pharma, Inc. | 5 | $121 |
| Novo Nordisk Inc | 5 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Exact Sciences Corporation | 3 | $85 |
Products named: VRAYLAR, AIRSUPRA, IBSRELA, VOQUEZNA, Ohtuvayre, LINZESS, REXULTI, TRELEGY ELLIPTA.
Industry payments across MA — which companies pay providers there.
